Monday, November 27, 2006 - 18:30

Innate Pharma SA, a biopharmaceutical company specialising in immunology and developing first-in-class* drugs targeting the innate immune system, announces the full exercise of the over-allotment option (or “greenshoe”) in the context of its initial public offering (IPO) on the Eurolist market (Compartment C) of Euronext Paris.

AttachmentSize
PR in english35.3 KB
CP en français51.79 KB